CDMO Technology Domain
Advanced Formulation — Page 2
State-of-the-art dosage form engineering: polymeric sustained-release matrices, lipid-based drug delivery, enteric-coated capsules, and novel excipient selection.
55
dossiers
Catecholamine Homeostasis & Executive Function
Catecholamine Homeostasis and Executive Function: Optimizing Nutritional Product Formulations
Achieving stable and predictable cognitive benefits from dopaminergic nutritional products is challenging due to exposure variability ('spike-and-crash' kinetics) and the complex interplay of precursors, cofactors, and enzymatic bottlenecks in catecholamine biosynthesis.
Cellular Longevity & Senolytics
Clock Gene Expression (CLOCK/BMAL1) Impact on Pharmacokinetics: Implications for Chrononutrition and Chronopharmacology
Current pharmaceutical and nutritional guidelines often neglect circadian rhythmicity, leading to suboptimal therapeutic efficacy and unpredictable pharmacokinetic profiles for molecular interventions. Integrating clock gene biology into dosing regimens requires precise understanding of ADME variations.
Microvascular Hemodynamics & Endothelial Integrity
Modulation of the Endothelial Glycocalyx and Vitamin K2-Dependent MGP Carboxylation in the Prevention of Vascular Calcification
Developing bioavailable formulations of vitamin K2 (MK-7) and novel compounds to robustly enhance endothelial glycocalyx integrity and MGP carboxylation for the prevention or reversal of vascular calcification presents significant delivery and stability challenges.
Precision Microbiome & Gut-Brain Axis
Hidden Pharmacodynamics of Pharmaceutical Formulations: Excipient, Impurity, and Oxidation Index Impact on Clinical Safety
Pharmaceutical and nutraceutical formulations often overlook the direct pharmacodynamic effects of excipients and the toxicity of oxidation byproducts, risking unforeseen clinical safety issues that extend beyond the API's profile.
Female Endocrine-Metabolic Crosstalk
Female Endocrine-Metabolic Axis: Formulation Technologies for Inositols and Antioxidants
Formulating stable, bioavailable, and patient-compliant products with precise inositol isomer ratios and sensitive antioxidants for female endocrine-metabolic health presents challenges in ingredient stability, dissolution, and avoiding paradoxical clinical effects from incorrect dosages.
Post-GLP-1 Metabolic Optimization
Amino-Peptide Matrices for Lean Mass Preservation in GLP-1 Receptor Agonist-Induced Gastroparesis
GLP-1 RA-induced gastroparesis and retained gastric contents present a significant challenge for effective oral nutrition delivery and lean mass preservation during weight loss therapy, especially in at-risk populations.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Technologies and Ingredients for Glycolysis-Restricted Medical Foods in Oncology Nutrition
Developing glycolysis-restricted Foods for Special Medical Purposes (FSMP) for oncology patients is challenged by cancer cachexia, patient dysgeusia, and the need for advanced solutions in lipid-based formulation and product stability.
Post-GLP-1 Metabolic Optimization
In Vivo Gene Editing via Lipid Nanoparticles: Base Editor Mechanisms and PCSK9 Targeting
Developing safe, durable, and highly targeted in vivo delivery systems for gene editing machinery (e.g., mRNA encoding base editors) to specific tissues like the liver via LNPs remains a significant challenge, requiring precise control over biodistribution and off-target effects.
Catecholamine Homeostasis & Executive Function
Kava (Piper methysticum) in Psychiatry: Clinical Effects, Mechanisms, and Safety Signals with Emphasis on Anxiety Disorders
Developing safe and effective Kava-derived anxiolytics is challenging due to inherent hepatotoxicity concerns and potential herb-drug interactions, necessitating novel formulation strategies to mitigate adverse events while preserving therapeutic efficacy.
Cellular Longevity & Senolytics
Targeted Mitochondrial Medicine: Synergistic Modulation of AMPK and NAD⁺ Salvage Pathways for Cardiometabolic Health
The challenge lies in developing stable, bioavailable, and synergistically effective combination formulations of NAD⁺ precursors and AMPK modulators to precisely target cellular bioenergetic decline in age-related cardiometabolic conditions.
Transmucosal Delivery & Dosage Form Engineering
Nutraceutical Pharmacokinetics: Advanced Delivery Systems for Improved Bioavailability
Many clinically relevant nutraceuticals exhibit poor oral bioavailability due to extensive first-pass metabolism and unfavorable physicochemical properties, making their therapeutic efficacy unpredictable in conventional forms.
Transmucosal Delivery & Dosage Form Engineering
Breakthroughs in Nutraceutical & Functional Food Technology: Delivery Systems, Green Manufacturing, and AI-Driven Precision Nutrition
Developing advanced nutraceuticals is challenged by low ingredient solubility, poor stability, and the lack of targeted or controlled release mechanisms, hindering optimal bioavailability and physiological efficacy. Ensuring robust evidence and regulatory acceptance for novel formulations further complicates development.
Post-GLP-1 Metabolic Optimization
Nutraceutical Toxicology and Herb-Drug Interactions (HDI/NDI): A Clinical Review of Six Critical Pharmacological Mechanisms
Developing safe and effective drug formulations requires comprehensive consideration of potential, often undisclosed, herb-drug interactions that can compromise efficacy or lead to life-threatening toxicities, especially with narrow therapeutic index compounds.
Intracellular Defense & IV-Alternatives
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.
Precision Microbiome & Gut-Brain Axis
Pharmacomicrobiomics: Gut Microbiota Modulation of Drug Efficacy and Nutraceutical Biotransformation
Integrating the profound and variable metabolic capacity of the gut microbiome into pharmaceutical development to ensure consistent drug efficacy and bioavailability across diverse patient populations is a significant hurdle.
Transmucosal Delivery & Dosage Form Engineering
Piperine-Mediated Potentiation of Direct Oral Anticoagulants: A Clinically Unrecognized Hemorrhagic Risk
Piperine, marketed as a 'bio-enhancer' in nutraceuticals, dangerously potentiates DOACs by inhibiting P-gp and CYP3A4, leading to critical hemorrhagic risk due to uncontrolled increases in drug exposure. This unrecognized interaction demands safer alternatives for enhancing polyphenol bioavailability.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Quantum Physics and Medicine: A Review of Common Aspects
Integrating quantum phenomena, essential for advanced diagnostics and computation, into stable and functional biomedical devices for precise clinical application amidst complex biological environments presents a significant CDMO hurdle.
Microvascular Hemodynamics & Endothelial Integrity
Common Aspects of Quantum Physics and Phlebology: A Literature Review
Developing precise, wavelength-optimized laser ablation and advanced imaging modalities for phlebology requires deep understanding of photon-tissue interaction and complex quantum phenomena, posing significant engineering and material science hurdles for consistent clinical outcomes.
Transmucosal Delivery & Dosage Form Engineering
Innovations in Softgel Capsule Technology: Shell Materials, Lipid Formulations, and Stability Modeling
Developing advanced softgel formulations to overcome low water solubility and variable bioavailability of drug candidates, while addressing manufacturing, stability, and release challenges associated with novel plant-based shell materials.
Post-GLP-1 Metabolic Optimization
Triple Agonists and Next-Generation Oral GLP-1s: Advancements in Metabolic Disorder Therapeutics
Formulating complex multi-receptor agonists and high-potency oral GLP-1 peptides requires advanced delivery systems to ensure bioavailability, stability, and patient adherence while mitigating gastrointestinal side effects.
Catecholamine Homeostasis & Executive Function
Clinical Nutrigenomics: One-Carbon Metabolism, MTHFR/COMT Polymorphisms, and Unmetabolized Folic Acid Toxicity
Developing stable, bioavailable dosage forms of 5-methyltetrahydrofolate (5-MTHF) that effectively bypass common one-carbon metabolism genetic polymorphisms (e.g., MTHFR, COMT) is critical to prevent unmetabolized folic acid (UMFA) toxicity and ensure optimal folate status. This requires precise formulation to overcome stability issues inherent to reduced folates while ensuring clinical efficacy across genetically diverse populations.
Intracellular Defense & IV-Alternatives
De Novo Generative AI Drug Design: Clinical Progress and Methodological Landscape
Developing novel therapeutic molecules with high specificity and optimized pharmacological profiles rapidly, particularly for challenging targets, requires innovative and efficient design methodologies beyond traditional discovery pipelines.
Transmucosal Delivery & Dosage Form Engineering
Physicochemical Challenges in Alcohol-Free Sublingual Sprays: Solutions for Enhanced Stability and Bioavailability
Formulating stable alcohol-free sublingual sprays presents significant challenges, particularly for complex blends of amino acids and lipophilic botanicals, due to issues like crystallisation, phase separation, and subsequent nozzle obstruction.
Cellular Longevity & Senolytics
BCS Class IV Senolytics: Nano-Micellar Flavonoid Delivery for Targeted Senescence Clearance
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.